NCT05673915 - Study of Transcranial Direct Current Stimulation to Treat Epilepsy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 12, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

February 28, 2026

Conditions

Focal EpilepsyGeneralized Onset EpilepsySleep-related Epileptic Encephalopathy

Interventions

DEVICE

ActivaDose II 0.1 mA transcranial direct current stimulation (tDCS)

Stimulation setting 0.1 mA daily for a 2-month period. Each daily treatment will last for approximately 30 minutes.

DEVICE

ActivaDose II 2.0 mA transcranial direct current stimulation (tDCS)

Stimulation setting 2.0 mA daily for a 2-month period. A Each daily treatment will last for approximately 30 minutes.

Trial Locations (1)

RECRUITING

Mayo Clinic Minnesota, Rochester